BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11905738)

  • 1. The role of extracellular matrix in small-cell lung cancer.
    Rintoul RC; Sethi T
    Lancet Oncol; 2001 Jul; 2(7):437-42. PubMed ID: 11905738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
    Hodkinson PS; Mackinnon AC; Sethi T
    Int J Radiat Biol; 2007; 83(11-12):733-41. PubMed ID: 17852559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
    Hartmann TN; Burger M; Burger JA
    J Biol Regul Homeost Agents; 2004; 18(2):126-30. PubMed ID: 15471215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
    Rintoul RC; Sethi T
    Clin Sci (Lond); 2002 Apr; 102(4):417-24. PubMed ID: 11914104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer: the importance of the extracellular matrix.
    Buttery RC; Rintoul RC; Sethi T
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1154-60. PubMed ID: 15109562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
    Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
    Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinases (MMP) in lung cancer].
    Nabeshima K; Shimao Y; Inoue T; Sameshima T
    Nihon Rinsho; 2002 May; 60 Suppl 5():103-9. PubMed ID: 12101637
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.
    Stetler-Stevenson WG
    Surg Oncol Clin N Am; 2001 Apr; 10(2):383-92, x. PubMed ID: 11382593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and lung cancer: a review.
    Shivapurkar N; Reddy J; Chaudhary PM; Gazdar AF
    J Cell Biochem; 2003 Apr; 88(5):885-98. PubMed ID: 12616528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
    Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
    Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
    Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
    Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
    Gutova M; Najbauer J; Gevorgyan A; Metz MZ; Weng Y; Shih CC; Aboody KS
    PLoS One; 2007 Feb; 2(2):e243. PubMed ID: 17327908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis.
    Murray MJ; Lessey BA
    Semin Reprod Endocrinol; 1999; 17(3):275-90. PubMed ID: 10797946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors].
    Roeb E; Matern S
    Z Gastroenterol; 2001 Sep; 39(9):807-13. PubMed ID: 11558074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracellular matrix--regulation of cancer invasion and metastasis].
    Watanabe H
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2058-61. PubMed ID: 21084803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.
    Martínez-García E; Irigoyen M; González-Moreno O; Corrales L; Teijeira A; Salvo E; Rouzaut A
    Toxicol Sci; 2010 Aug; 116(2):467-76. PubMed ID: 20457658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New functions of stromal proteases and their inhibitors in tumor progression.
    Noel A; Albert V; Bajou K; Bisson C; Devy L; Frankenne F; Maquoi E; Masson V; Sounni NE; Foidart JM
    Surg Oncol Clin N Am; 2001 Apr; 10(2):417-32, x-xi. PubMed ID: 11382595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.